We examined the status of leptin signaling under the backdrop of pathological CNS TDP-43 levels providing, to our knowledge, the first insights into the association between the pathways that link alterations in leptin signaling to the pathogenesis of ALS. This evidence concerns the gene LEP and amyotrophic lateral sclerosis.